| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |